RMIT scientists in Melbourne have led an international collaboration that potentially unlocks better treatment of viral diseases, including the flu and common cold.
The results were published in the prestigious scientific and medical journal Nature Communications.
Each year the flu virus sends 13,500 Australians to hospital and causes more than 3000 deaths among those aged over 50. The global burden is also staggering, with more than 5 million cases of infection annually with up to 10 per cent resulting in death.
The RMIT senior authors, Dr Stavros Selemidis (ARC Future Fellow) and Dr Eunice To (first author), collaborated with Professor Doug Brooks from University South Australia, Professor John O’Leary from Trinity College Dublin, Monash University’s Professor Christopher Porter, and other scientists and clinicians to investigate how viruses cause disease in humans.
The researchers discovered that a 1.5 billion-year-old cell biological process found in plants, fungi and mammals enhances viral disease in mice and highly likely also in humans. They identified a protein, Nox2 oxidase, that is activated by viruses, including influenza, rhinovirus (the common cold), dengue and HIV.
Once activated, Nox2 oxidase suppresses the body’s key antiviral reaction and its ability to fight and clear the viral infection, which in turn results in a stronger or more virulent disease in mice.
The study also investigated a new prototype drug to treat these debilitating viral diseases.
The researchers found that the Nox2 oxidase protein activated by the viruses is located in a cell compartment called endosomes. They carefully modified a chemical that inhibits or restrains the activity of Nox2 oxidase.
Their customised drug was found to be very effective at suppressing disease caused by influenza infection.
Selemidis, head of the Oxidant and Inflammation Biology Group within the Chronic Infectious and Inflammatory Diseases program at RMIT, said: “Current treatment strategies are limited as they specifically target circulating viruses and have either unknown or very little effect against new viruses that enter the human population.
“We have identified a protein of the immune system that contributes to the disease caused by flu viruses irrespective of their strain.
“We also developed a novel drug delivery system to target this protein, which drastically alleviated the burden of viral disease.
“The strength of this work is the multidisciplinary approach taken and the degree of collaboration. It includes researchers and clinicians from eight universities across Australia, the United States and Ireland.
“This work attracted considerable interest at the NADPH Oxidase GORDON conference in the USA last year.”
To said: “This work identifies a treatment strategy that has the potential to alleviate the symptoms caused by some of the most devastating viruses worldwide, including the flu.”
The Latest on: Viral diseases
- Water villages threatened by infectious diseases on October 7, 2018 at 1:00 am
KOTA KINABALU: Water villages here are facing threat of infectious diseases particularly dengue fever, tuberculosis and cholera following the increase of these diseases recently. Kota Kinabalu Epidemo... […]
- Keeping safe from West Nile Virus on October 7, 2018 at 12:11 am
According to the Centers for Disease Control and Prevention (www.cdc.gov) West Nile Virus “is a virus most commonly spread to people by mosquito bites. In North America, cases of West Nile virus (WNV) ... […]
- VIDEO Fungal Disease Awareness Week on October 5, 2018 at 2:09 pm
SAN FRANCISCO — In this video from IDWeek, Snigdha Vallabhaneni, MD, MPH, medical epidemiologist in the CDC’s Mycotic Diseases Branch, advises clinicians to “think fungus.” Vallabhaneni spoke with Inf... […]
- Has Innovation Just Become An Infectious Disease? on October 5, 2018 at 7:32 am
Be careful, the company is febrile. Fluttering hearts, sweaty palms, anxiety, and delusions of grandeur are the other symptoms that seem to be transmitted from company to company--starting with the Ch... […]
- Glow-In-The-Dark Paper Test Rapidly Detects Infectious Diseases on October 5, 2018 at 7:25 am
Researchers at Eindhoven University of Technology in The Netherlands and Keio University in Japan have developed a paper-based diagnostic test, which can be used to rapidly and inexpensively test for ... […]
- Despite Infectious Disease Outbreaks Linked To Opioid Crisis, Most Substance Abuse Facilities Don’t Test For HIV Or HCV on October 5, 2018 at 6:46 am
America’s opioid epidemic continues to take lives at a staggering rate. According to preliminary estimates from the Centers for Disease Control and Prevention (CDC), drug overdoses killed about 72,000 ... […]
- VIDEO: Infectious diseases can follow you to space on October 4, 2018 at 6:59 pm
SAN FRANCISCO — NASA astronaut Kate Rubins, PhD, spoke with Infectious Disease News at IDWeek about space travel and the effects it can have on physiology and the human microbiome. Rubins explained th... […]
- Infectious Disease Researcher Explains How Chickenpox Vaccine Can Save Lives on October 4, 2018 at 11:00 am
But others questioned why it would be necessary, since chickenpox is relatively mild for most children, and some even insisted the disease is a “healthy” rite of passage for kids. I decided to talk to ... […]
- Glow-in-the-Dark Paper as Rapid Test for Infectious Diseases on October 4, 2018 at 6:23 am
Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) present a practicable and reliable way to test for infectious diseases. All you need are a special glo... […]
- Glow-in-the-dark paper as a rapid test for infectious diseases on October 4, 2018 at 5:32 am
This paper strip (extremely zoomed in) contains two copies of the test. The three glowing dots per test indicate that you can check on three different antibodies within one test. Credit: Bart van ... […]
via Google News and Bing News